H.R. 6348 · 114th Congress

To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.

Stage
In committee
Sponsor
Alan Grayson
Introduced
2016-11-17
Latest action
2016-11-17 · Introduced in House

Text